Stock Events

Stock Events

Jiangsu Hengrui Pharmaceuticals. 

€5.90
16
+€0.15+2.61%Thursday 07:14

Statistics

Day High
5.9
Day Low
5.9
52W High
8.55
52W Low
4.86
Volume
0
Avg. Volume
3
Mkt Cap
39.16B
P/E Ratio
-
Dividend Yield
0.42%
Dividend
0.03

Upcoming

Dividends

0.42%Dividend Yield
May 2026
€0.03
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Oct 27Expected
Q1 2026
Q3 2026
0.04
0.04
0.05
0.05
Expected EPS
0.044505468327765
Actual EPS
0.049511033850000004

Financials

27.48%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.22BRevenue
1.16BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0BO.MU. It's not an investment recommendation.
Apple
2
AAPL
Microsoft
2
MSF.XETRA
Microsoft
2
MSFT
Realty Income
2
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Shanghai Fosun Pharmaceutical (Group).
600196.SHG
Mkt Cap64.22B
Fosun Pharma offers a broad range of pharmaceutical products, directly competing in several therapeutic areas with Jiangsu Hengrui.
Yunnan Baiyao Group.
000538.SZ
Mkt Cap98.68B
Yunnan Baiyao operates in the pharmaceutical sector, offering products that compete in the traditional Chinese medicine segment against Jiangsu Hengrui's offerings.
Sichuan Kelun Pharmaceutical
002422.SZ
Mkt Cap39.2B
Jiangsu Hengrui and Kangmei Pharmaceutical compete in the pharmaceutical market, particularly in the development and manufacturing of medicine and health-related products.
Tonghua Dongbao Medicines.
600867.SHG
Mkt Cap16.02B
Tonghua Dongbao Pharmaceutical is a direct competitor in the pharmaceutical industry, focusing on insulin and other diabetes-related medicines, areas Jiangsu Hengrui is expanding into.
Zhejiang NHU.
002001.SZ
Mkt Cap55.67B
Zhejiang Medicine is a competitor in the pharmaceutical sector, with a focus on the research, development, production, and sale of pharmaceutical products, overlapping with Jiangsu Hengrui's market.
Joincare Pharmaceutical Group Industry.
600380.SHG
Mkt Cap18.08B
Jiangsu Hengrui and Harbin Pharmaceutical Group hold competitive positions in the pharmaceutical industry, particularly in the production and sale of pharmaceutical products.
Huadong Medicine.
000963.SZ
Mkt Cap81.74B
Huadong Medicine competes with Jiangsu Hengrui in the pharmaceutical sector, especially in the areas of oncology and anti-infective products.
Shenzhen Kangtai Biological Products
300601.SZ
Mkt Cap34.83B
Kanghong Pharmaceuticals is a competitor in the ophthalmology sector, a field Jiangsu Hengrui is involved in through its development of ophthalmic products.
Lepu Medical Technology (Beijing).
300003.SZ
Mkt Cap43.1B
Lepu Medical Technology competes with Jiangsu Hengrui in the healthcare sector, particularly in the development and manufacturing of medical devices and pharmaceuticals.
Shenzhen Salubris Pharmaceuticals.
002294.SZ
Mkt Cap37.85B
Sinopharm Group is a major competitor in the pharmaceutical and healthcare industry, with a broad range of products and services that compete with Jiangsu Hengrui's offerings.

About

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Show More
CEO
Sun Piaoyang
Employees
20602
Country
China
ISIN
CNE100006XS6
WKN
000A41984

Listings

MX
MX
1276N.MX
OTC Link
US
JHPCY
HK
HK
1276.HK
F
DE
0BO.F

0 Comments

Share your thoughts

FAQs

What is Jiangsu Hengrui Pharmaceuticals. stock price today?▼
The current price of 0BO.MU is €5.90 EUR — it has increased by +2.61% in the past 24 hours. Watch Jiangsu Hengrui Pharmaceuticals. stock price performance more closely on the chart.
What is Jiangsu Hengrui Pharmaceuticals. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Jiangsu Hengrui Pharmaceuticals. stocks are traded under the ticker 0BO.MU.
Is Jiangsu Hengrui Pharmaceuticals. stock price growing?▼
0BO.MU stock has risen by +3.51% compared to the previous week, the month change is a +7.27% rise, over the last year Jiangsu Hengrui Pharmaceuticals. has showed a -26.25% decrease.
What is Jiangsu Hengrui Pharmaceuticals. market cap?▼
Today Jiangsu Hengrui Pharmaceuticals. has the market capitalization of 39.16B
When is the next Jiangsu Hengrui Pharmaceuticals. earnings date?▼
Jiangsu Hengrui Pharmaceuticals. is going to release the next earnings report on April 19, 2027.
What were Jiangsu Hengrui Pharmaceuticals. earnings last quarter?▼
0BO.MU earnings for the last quarter are 0.05 EUR per share, whereas the estimation was 0.04 EUR resulting in a +11.25% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Jiangsu Hengrui Pharmaceuticals. revenue for the last year?▼
Jiangsu Hengrui Pharmaceuticals. revenue for the last year amounts to 4.22B EUR.
What is Jiangsu Hengrui Pharmaceuticals. net income for the last year?▼
0BO.MU net income for the last year is 1.16B EUR.
Does Jiangsu Hengrui Pharmaceuticals. pay dividends?▼
Yes, 0BO.MU dividends are paid annual. The last dividend per share was 0.03 . As of today, Dividend Yield (FWD)% is 0.42%.
How many employees does Jiangsu Hengrui Pharmaceuticals. have?▼
As of November 7, 2026, the company has 20,602 employees.
In which sector is Jiangsu Hengrui Pharmaceuticals. located?▼
Jiangsu Hengrui Pharmaceuticals. operates in the Health & Wellness sector.
When did Jiangsu Hengrui Pharmaceuticals. complete a stock split?▼
Jiangsu Hengrui Pharmaceuticals. has not had any recent stock splits.
Where is Jiangsu Hengrui Pharmaceuticals. headquartered?▼
Jiangsu Hengrui Pharmaceuticals. is headquartered in Lianyungang, China.